U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula Fe.2O4S.6H2O.2H4N
Molecular Weight 392.139
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FERROUS AMMONIUM SULFATE HEXAHYDRATE

SMILES

[NH4+].[NH4+].O.O.O.O.O.O.[Fe++].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O

InChI

InChIKey=MQLVWQSVRZVNIP-UHFFFAOYSA-L
InChI=1S/Fe.2H3N.2H2O4S.6H2O/c;;;2*1-5(2,3)4;;;;;;/h;2*1H3;2*(H2,1,2,3,4);6*1H2/q+2;;;;;;;;;;/p-2

HIDE SMILES / InChI

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Fe
Molecular Weight 55.845
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula O4S
Molecular Weight 96.063
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula H4N
Molecular Weight 18.0385
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/3541174 | https://books.google.ru/books?id=7mxyBgAAQBAJ&pg=PA13&lpg=PA13&dq=%22ferrous+iodide%22+anemia&source=bl&ots=ZGyFhUiJZ4&sig=IZOhRVaGmlwX7GcqgoE6rnCsCa4&hl=ru&sa=X&ved=0ahUKEwjYu7PCyYHUAhWiQpoKHR6cCfcQ6AEIUjAJ#v=onepage&q=%22ferrous%20iodide%22&f=false

There is no information about biological and pharmacological application of Iron(II) fluoride (also known as ferrous fluoride). It is known, that this substance is used to catalyze some organic reactions.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Primary
Ferro Sanol Duodenal

Approved Use

Ferro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia.
Curative
RADIOGARDASE

Approved Use

Insoluble Prussian blue is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination.

Launch Date

2003
PubMed

PubMed

TitleDatePubMed
FERROUS IODIDE AND LINOLEIC ACID IN VITAMIN A DEFICIENCY. A REPLY TO CERTAIN CRITICISMS.
1932 Nov 11
[Ferrous lactate as an oral iron preparation for therapeutic use].
1954 Nov 27
Clinical appraisal of drugs with special reference to a new chelate hematinic.
1957 Jul 11
[FERROUS ASPARTATE IN THERAPY].
1964 Jan 1
[Historical notes on the therapy of depression].
1986 Nov 22
Determination of water in ferrous lactate by near infrared reflectance spectroscopy with a fibre-optic probe.
1997 Oct
Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis.
2007
Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice.
2009
Bioleaching of heavy metals from sewage sludge by indigenous iron-oxidizing microorganisms using ammonium ferrous sulfate and ferrous sulfate as energy sources: a comparative study.
2009 Nov 15
The effect of iron treatment on adhesion molecules in patients with iron deficiency anemia.
2010 Dec
Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis.
2011 Jun 10
Tolerability of different oral iron supplements: a systematic review.
2013 Apr
A practical and successful desensitization protocol for immediate hypersensitivity reactions to iron salts.
2014
Patents

Sample Use Guides

Adults should usually take one capsule a day. In cases of pronounced iron deficiency, adults can be given a dosage 2 to 3 times higher at the beginning of therapy. A daily dose of more than 5 mg Fe2+/kg body weight should in-well founded exceptional cases not be exceeded.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:17:49 GMT 2025
Edited
by admin
on Mon Mar 31 20:17:49 GMT 2025
Record UNII
99A04ICQ3J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMMONIUM FERROUS SULFATE HEXAHYDRATE
MI  
Preferred Name English
FERROUS AMMONIUM SULFATE HEXAHYDRATE
Common Name English
DIAMMONIUM IRON(II) SULFATE HEXAHYDRATE
Systematic Name English
AMMONIUM FERROUS SULFATE HEXAHYDRATE [MI]
Common Name English
SULFURIC ACID, AMMONIUM IRON(2+) SALT (2:2:1), HEXAHYDRATE
Systematic Name English
DIAMMONIUM IRON DISULFATE HEXAHYDRATE
Systematic Name English
Classification Tree Code System Code
EPA PESTICIDE CODE 50509
Created by admin on Mon Mar 31 20:17:49 GMT 2025 , Edited by admin on Mon Mar 31 20:17:49 GMT 2025
Code System Code Type Description
CHEBI
76181
Created by admin on Mon Mar 31 20:17:49 GMT 2025 , Edited by admin on Mon Mar 31 20:17:49 GMT 2025
PRIMARY
FDA UNII
99A04ICQ3J
Created by admin on Mon Mar 31 20:17:49 GMT 2025 , Edited by admin on Mon Mar 31 20:17:49 GMT 2025
PRIMARY
MERCK INDEX
m1788
Created by admin on Mon Mar 31 20:17:49 GMT 2025 , Edited by admin on Mon Mar 31 20:17:49 GMT 2025
PRIMARY Merck Index
PUBCHEM
15942308
Created by admin on Mon Mar 31 20:17:49 GMT 2025 , Edited by admin on Mon Mar 31 20:17:49 GMT 2025
PRIMARY
EPA CompTox
DTXSID70897287
Created by admin on Mon Mar 31 20:17:49 GMT 2025 , Edited by admin on Mon Mar 31 20:17:49 GMT 2025
PRIMARY
CAS
7783-85-9
Created by admin on Mon Mar 31 20:17:49 GMT 2025 , Edited by admin on Mon Mar 31 20:17:49 GMT 2025
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE
PARENT -> SALT/SOLVATE